Company
Vycor Medical
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
1
510(k), De Novo and PMA
Device trials
0
As lead sponsor, any status
Adverse event reports
0
Received Nov 1, 2025 to Nov 20, 2026
Recall records
1
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Public company. Figures from its SEC financial statements, plus private placements it reported on Form D.
Listed
VYCO
OTC · VYCOR MEDICAL INC
Public float
$1.7M
Value of shares held by non-insiders on Jun 30, 2025
Revenue
$1.9M
Fiscal year ending Dec 31, 2025
Net income
-$72K
Fiscal year ending Dec 31, 2025
R&D spending
$10K
Fiscal year ending Dec 31, 2025
Cash
$199K
As of Sep 30, 2026
Long-term debt
$133K
As of Sep 30, 2026
Shares outstanding
33.4M
As of Nov 13, 2026
Private placements (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
| First sale | Type | Raised | Round size | Investors | Exemption and agent | Filing |
|---|---|---|---|---|---|---|
| Jan 11, 2017 | Equity | $619K | $1.0M | 54 | Rule 506(b)Agent: Garden State Securities, Inc.Commissions $8K | Form D ↗Jan 23, 2017 |
4 more funding rounds with a free account
Company details
From the company's latest Form D.
- Legal name
- VYCOR MEDICAL INC
- Headquarters
- Boca Raton, Florida
- Incorporated
- Delaware over five years before filing
- Entity type
- Corporation
- Revenue range
- Decline to Disclose
- Industry filed under
- Other Health Care
- SEC filer
- CIK 1424768 ↗
Executives, directors and promoters
As listed on the latest Form D.
6 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors from funding announcements and the firms' own portfolio pages.
No 5%+ shareholder filings, SBIR grants or venture investors found under the name Vycor Medical.
Latest FDA decisions
K202694 · Decided Jan 14, 2021 · 120 days after receipt
Device type: Retractor, Self-Retaining, For Neurosurgery (GZT) · Neurology & Neurosurgery
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
No device trials list this company as lead sponsor.
Reports received
0
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
No reports to chart for this view.
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
No device types to rank.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
No brand names to rank.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0673-2013 · Started Aug 21, 2012 · Posted by FDA Jan 17, 2013
Reason given: Vycor Medical recalled their VBAS (Vycor Viewsite Brain Access System) because an unidentified black fiber was found on the device.
Cause as FDA categorized it: Equipment maintenance · Device type: Retractor, Self-Retaining, For Neurosurgery (GZT)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.